Literature DB >> 25685929

Identification of BRAF 3'UTR Isoforms in Melanoma.

Andrea Marranci1, Andrea Tuccoli2, Marianna Vitiello3, Elisa Mercoledi2, Samanta Sarti3, Simone Lubrano3, Monica Evangelista4, Antonella Fogli5, Camilo Valdes6, Francesco Russo7, Massimo Dal Monte8, Maria A Caligo5, Marco Pellegrini9, Enrico Capobianco10, Nicholas Tsinoremas6, Laura Poliseno11.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25685929     DOI： 10.1038/jid.2015.47

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN： 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  14 in total

1.  Mitochondrial localization and regulation of BRAFV600E in thyroid cancer: a clinically used RAF inhibitor is unable to block the mitochondrial activities of BRAFV600E.

Authors:  Min Hee Lee; Seong Eun Lee; Dong Wook Kim; Min Jeong Ryu; Sung Jin Kim; Sung Joong Kim; Yong Kyoung Kim; Ji Hoon Park; Gi Ryang Kweon; Jin Man Kim; Jung Uee Lee; Valentina De Falco; Young Suk Jo; Minho Shong
Journal:  J Clin Endocrinol Metab       Date:  2010-10-06       Impact factor: 5.958

Review 2.  BRAFV600E: implications for carcinogenesis and molecular therapy.

Authors:  Emma R Cantwell-Dorris; John J O'Leary; Orla M Sheils
Journal:  Mol Cancer Ther       Date:  2011-03       Impact factor: 6.261

3.  Raf family kinases: old dogs have learned new tricks.

Authors:  David Matallanas; Marc Birtwistle; David Romano; Armin Zebisch; Jens Rauch; Alexander von Kriegsheim; Walter Kolch
Journal:  Genes Cancer       Date:  2011-03

4.  Alternative splicing of BRAF transcripts and characterization of C-terminally truncated B-Raf isoforms in colorectal cancer.

Authors:  Benjamin Hirschi; Frank T Kolligs
Journal:  Int J Cancer       Date:  2013-02-27       Impact factor: 7.396

Review 5.  The multilayered complexity of ceRNA crosstalk and competition.

Authors:  Yvonne Tay; John Rinn; Pier Paolo Pandolfi
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962

Review 6.  Systemic treatment for BRAF-mutant melanoma: where do we go next?

Authors:  Alexander M Menzies; Georgina V Long
Journal:  Lancet Oncol       Date:  2014-08       Impact factor: 41.316

7.  Expressed pseudogenes in the transcriptional landscape of human cancers.

Authors:  Shanker Kalyana-Sundaram; Chandan Kumar-Sinha; Sunita Shankar; Dan R Robinson; Yi-Mi Wu; Xuhong Cao; Irfan A Asangani; Vishal Kothari; John R Prensner; Robert J Lonigro; Matthew K Iyer; Terrence Barrette; Achiraman Shanmugam; Saravana M Dhanasekaran; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Cell       Date:  2012-06-22       Impact factor: 41.582

8.  RAF inhibitor resistance is mediated by dimerization of aberrantly spliced BRAF(V600E).

Authors:  Poulikos I Poulikakos; Yogindra Persaud; Manickam Janakiraman; Xiangju Kong; Charles Ng; Gatien Moriceau; Hubing Shi; Mohammad Atefi; Bjoern Titz; May Tal Gabay; Maayan Salton; Kimberly B Dahlman; Madhavi Tadi; Jennifer A Wargo; Keith T Flaherty; Mark C Kelley; Tom Misteli; Paul B Chapman; Jeffrey A Sosman; Thomas G Graeber; Antoni Ribas; Roger S Lo; Neal Rosen; David B Solit
Journal:  Nature       Date:  2011-11-23       Impact factor: 49.962

9.  Braf(V600E) cooperates with Pten loss to induce metastatic melanoma.

Authors:  David Dankort; David P Curley; Robert A Cartlidge; Betsy Nelson; Anthony N Karnezis; William E Damsky; Mingjian J You; Ronald A DePinho; Martin McMahon; Marcus Bosenberg
Journal:  Nat Genet       Date:  2009-03-12       Impact factor: 38.330

10.  BRAFV600E negatively regulates the AKT pathway in melanoma cell lines.

Authors:  Brenden Chen; Christine Tardell; Brian Higgins; Kathryn Packman; John F Boylan; Huifeng Niu
Journal:  PLoS One       Date:  2012-08-03       Impact factor: 3.240
View more
  8 in total

1.  Systematic evaluation of the microRNAome through miR-CATCHv2.0 identifies positive and negative regulators of BRAF-X1 mRNA.

Authors:  Andrea Marranci; Romina D'Aurizio; Sebastian Vencken; Serena Mero; Elena Guzzolino; Milena Rizzo; Letizia Pitto; Marco Pellegrini; Giovanna Chiorino; Catherine M Greene; Laura Poliseno
Journal:  RNA Biol       Date:  2019-04-19       Impact factor: 4.652

2.  High-Throughput Identification of miRNA-Target Interactions in Melanoma Using miR-CATCHv2.0.

Authors:  Andrea Marranci; Romina D'Aurizio; Milena Rizzo; Catherine M Greene; Laura Poliseno
Journal:  Methods Mol Biol       Date:  2021

Review 3.  RNA-biology ruling cancer progression? Focus on 3'UTRs and splicing.

Authors:  Ayse Elif Erson-Bensan
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

4.  BRAF(V600E) Kinase Domain Duplication Identified in Therapy-Refractory Melanoma Patient-Derived Xenografts.

Authors:  Kristel Kemper; Oscar Krijgsman; Xiangjun Kong; Paulien Cornelissen-Steijger; Aida Shahrabi; Fleur Weeber; Daphne L van der Velden; Onno B Bleijerveld; Thomas Kuilman; Roel J C Kluin; Chong Sun; Emile E Voest; Young Seok Ju; Ton N M Schumacher; A F Maarten Altelaar; Ultan McDermott; David J Adams; Christian U Blank; John B Haanen; Daniel S Peeper
Journal:  Cell Rep       Date:  2016-06-16       Impact factor: 9.423

5.  Ensemble Modeling Approach Targeting Heterogeneous RNA-Seq data: Application to Melanoma Pseudogenes.

Authors:  Enrico Capobianco; Camilo Valdes; Samanta Sarti; Zhijie Jiang; Laura Poliseno; Nicolas F Tsinoremas
Journal:  Sci Rep       Date:  2017-12-11       Impact factor: 4.379

6.  The landscape of BRAF transcript and protein variants in human cancer.

Authors:  Andrea Marranci; Zhijie Jiang; Marianna Vitiello; Elena Guzzolino; Laura Comelli; Samanta Sarti; Simone Lubrano; Cinzia Franchin; Ileabett Echevarría-Vargas; Andrea Tuccoli; Alberto Mercatanti; Monica Evangelista; Paolo Sportoletti; Giorgio Cozza; Ettore Luzi; Enrico Capobianco; Jessie Villanueva; Giorgio Arrigoni; Giovanni Signore; Silvia Rocchiccioli; Letizia Pitto; Nicholas Tsinoremas; Laura Poliseno
Journal:  Mol Cancer       Date:  2017-04-28       Impact factor: 27.401

Review 7.  Pseudogenes in Human Cancer.

Authors:  Laura Poliseno; Andrea Marranci; Pier Paolo Pandolfi
Journal:  Front Med (Lausanne)       Date:  2015-09-25

8.  Alkaline Phosphatase-Positive Immortal Mouse Embryo Fibroblasts Are Cells in a Transitional Reprogramming State Induced to Face Environmental Stresses.

Authors:  Monica Evangelista; Mariama El Baroudi; Milena Rizzo; Andrea Tuccoli; Laura Poliseno; Marco Pellegrini; Giuseppe Rainaldi
Journal:  Genet Epigenet       Date:  2015-12-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.